Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can telehealth match In-Person therapy for kids with anxiety?

NCT ID NCT06934525

Symptom relief Sponsor: Bradley Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests whether giving cognitive behavioral therapy (CBT) in person, via video, or a mix of both works best for children aged 5-18 with anxiety or OCD. About 500 kids will be randomly assigned to one of three delivery methods. The goal is to find out which approach improves access and results, helping more families get effective care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 501 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Aug 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 5-18 inclusive * Primary or co-primary DSM-V diagnosis of anxiety or OCD * Symptom duration of at least 3 months * Outpatient care needed * Presence of a stable parent, or guardian, who can participate in treatment Exclusion Criteria: * Other primary or co-primary psychiatric disorder which requires initiation of other active current treatment * Acute suicidality * Concurrent psychotherapy * Chronic medical illness that would preclude their active participation in treatment * Treatment with psychotropic medication that is not stable

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Agoraphobia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agoraphobia anxiety anxiety disorder generalized anxiety disorder mutism obsessive-compulsive disorder obsessive-compulsive personality disorder panic disorder phobic disorder separation anxiety disorder social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Agoraphobia Anxiety Anxiety disorder Generalized anxiety Generalized anxiety disorder Obsessive compulsive disorder OCD OCD Panic disorder Pediatric anxiety disorders Pediatric disorders PHOBIA Selective mutism Separation anxiety Social anxiety Social anxiety disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bradley Hospital

    RECRUITING

    East Providence, Rhode Island, 02915, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.